About
Racquel Bracken is a biotech venture capitalist who joined Venrock in 2016 to lead pharmaceutical and biotech investments and company creation activities. She serves as Board Chair at MBrace Therapeutics, board member at Cyteir Therapeutics and Scithera, and acting CEO at Confluence, while also co-founding Federation Bio where she previously served as CEO. Prior to Venrock, Bracken held business development and commercial roles at Clovis Oncology, where she led acquisitions and the commercial launch of a PARP inhibitor program, and earlier worked as an investor at Domain Associates and consultant at Easton Associates focused on healthcare.
Experience
- ScitheraBoard Membercurrent2025 — presentSan Diego, California, United States
- Topaz TherapeuticsBoard Membercurrent2024 — presentSan Francisco, California, United States
- MBrace TherapeuticsBoard Membercurrent2021 — presentSan Diego, California, United States
- Essential Access HealthBoard Member, Treasurercurrent2019 — present
- VenrockGeneral Partnercurrent2016 — presentPalo Alto, California, United States
- Confluence Therapeutics, IncActing Chief Executive Officer2022 — 2024South San Francisco, California, United States
- Cyteir TherapeuticsBoard Member2017 — 2023Lexington, Massachusetts, United States
- Federation BioCEO and co-founder2018 — 2020San Francisco Bay Area
- Clovis OncologyMarketing Director2015 — 2016Boulder
- Clovis OncologyHead of Business Development2009 — 2016Boulder, CO
- Domain AssociatesAssociate2006 — 2009Princeton, NJ
- Easton AssociatesAnalyst2005 — 2006New York, NY
Skills & more
Corporate Development3Venture Capital3Mergers & Acquisitions3Biotechnology6Lifesciences1Commercialization3Due Diligence2Valuation1Private EquityBusiness Strategy3Start-ups8Medical Devices2
+8 more
Life SciencesOncologyDrug DevelopmentClinical DevelopmentBusiness DevelopmentStrategyStrategic PlanningPharmaceutical IndustryFrom Racquel's professional profile.
Colleagues at Venrock
Abe Valdez
IT Manager at Venrock
Andrew Gottesdiener
VHCP at Venrock
Andy Wardle
VHCP at Venrock
Bailie Salk
Investor at Venrock
Bambie Guzman
Office Manager & Executive Assistant at Venrock
Bob Kocher
Co-Founder of Lyra Health; Partner at Venrock
Bong Koh
VHCP at Venrock
Brad Walan
VP of IT and Security at Venrock
Frequently asked questions
- Who is Racquel Bracken?
- Racquel Bracken is a biotech venture capitalist who joined Venrock in 2016 to lead pharmaceutical and biotech investments and company creation activities. She serves as Board Chair at MBrace Therapeutics, board member at Cyteir Therapeutics and Scithera, and acting CEO at Confluence, while also co-founding Federation Bio where she previously served as CEO. Prior to Venrock, Bracken held business development and commercial roles at Clovis Oncology, where she led acquisitions and the commercial launch of a PARP inhibitor program, and earlier worked as an investor at Domain Associates and consultant at Easton Associates focused on healthcare.
- Where does Racquel Bracken work?
- Racquel Bracken is Partner at Venrock.
- Where did Racquel Bracken go to school?
- Racquel Bracken studied at Harvard University (AB, Molecular Biology).
Same school
Also attended Harvard University1,558
Alfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalGBill GatesCo-founder of Microsoft; Chair of the Gates Foundation
+ 1,552 more
